Empagliflozin improves kidney outcomes in patients with heart failure and CKD

被引：0
|
作者：
Ellen F. Carney
机构：
[1] Nature Reviews Nephrology,
来源：
Nature Reviews Nephrology | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：14 / 14
相关论文
共 50 条
  • [41] Strategies to Reduce Rehospitalization in Patients with CKD and Kidney Failure
    Doshi, Simit
    Wish, Jay B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (02): : 328 - 334
  • [42] Cell therapy improves outcomes in heart failure
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2016, 13 (6) : 311 - 311
  • [43] Outcomes with inpatient use of midodrine in patients with heart failure and kidney failure on maintenance dialysis
    Patel, Neev
    Concejo, Bruno Alvarez
    Lo, Kevin Bryan
    Mishra, Meenakshi
    Kattubadi, Ayeesha
    Rangaswami, Janani
    ACTA CARDIOLOGICA, 2024, 79 (05) : 545 - 548
  • [44] Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure (vol 7, e249305, 2024)
    Modzelewski, K. L.
    Pipilas, A.
    Bosch, N. A.
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [45] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    Anker, Stefan D.
    Butler, Javed
    Usman, Muhammad Shariq
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans Pieter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Iwata, Tomoko
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    NATURE MEDICINE, 2022, 28 (12) : 2480 - 2481
  • [46] BUDGET IMPACT ANALYSIS OF EMPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN SWEDEN
    Kontogiannis, V
    Karlsdotter, K.
    Rinciog, C.
    Gregory, E.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [47] The effects on empagliflozin on diuretics reduction in outpatient heart failure patients
    Kim, B. Bong-Joon
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 98 - 99
  • [48] Empagliflozin Compliance and Influencing Factors in Patients with Heart Failure and Diabetes
    Alvarez, Carlos A.
    Perkins, Aaron
    Sigler, Meredith A.
    Yang, Hui
    Caberwal, Harjeet
    Ebrahimi, Ramin
    DIABETES, 2023, 72
  • [49] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    Nature Medicine, 2022, 28 : 2480 - 2481
  • [50] Progress of patients hospitalized with acute heart failure treated with empagliflozin
    Raya-Cruz, Manuel
    Jurado, Javier Gasc on
    Torre, Gonzalo Olalla de la
    Ufar, Nicolas Mont
    Sanchez, Agustin Rodriguez
    Delgado, Francisco G. omez
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, : e240027
12345